• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Exostar, BT partner

Exostar, BT partner

October 16, 2014
CenterWatch Staff

Exostar, a Herndon, Va.-based provider of secure, cloud-based solutions that improve collaboration, information sharing and supply chain management for communities of partners, has become a specialist member of the BT for Life Sciences partner ecosystem. Exostar’s secure identity and access management (IAM) and enterprise federation solutions now can be paired with BT’s Workbench Informatics solution for scientists.

BT for Life Sciences provides cloud-based solutions that enable customers to do better, faster science, radically reducing the time required for the R&D process. BT’s Workbench Informatics solution brings together key applications and datasets, presented in a way that makes it easy for the scientist to launch virtual compute environments. This simplifies predictive simulations, allowing them to run faster and shortening the R&D discovery process. The service brings flexibility, including cost-effective pay-as-you-go and ramp up/ramp down options.

With the Exostar IAM solution as a secure access point, BT’s life sciences customers now can utilize a virtual scientist’s workbench in the cloud and collaborate with hundreds of partners and third-party applications throughout the Exostar life sciences community.

The platform also will provide heightened security for user information and intellectual property, ensuring organizations and individuals now can collaborate with confidence when sensitive and valuable information is involved. Exostar’s Life Sciences Identity Hub is a scalable solution where asset owners maintain control over access, which the Identity Hub enforces while offering individuals a single sign-on user experience.

Yury Rozenman, head of business development, life sciences for BT Global Services, said, “By connecting BT’s Workbench Informatics and other BT for Life Sciences solutions to the Exostar Life Sciences Identity Hub, companies can leverage access to a robust, global collaboration environment without compromising security.”

Exostar currently has more than 12,000 users, 550 organizations, seven federated organizations and 18 federated applications in its life sciences community. Exostar is experiencing rapid growth in life sciences global collaboration, with member organizations including Merck, AstraZeneca and MedImmune, along with their CRO, academic, laboratory and investigator partners.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing